First-in-human Clinical Study of Mts105 for Advanced Hepatocellular Carcinoma
Latest Information Update: 22 Nov 2024
Price :
$35 *
At a glance
- Drugs MTS 105 (Primary)
- Indications Liver cancer
- Focus Adverse reactions; First in man
- 22 Nov 2024 New trial record